Skip header and navigation

2 records – page 1 of 1.

Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study.

https://arctichealth.org/en/permalink/ahliterature168745
Source
Eur J Clin Microbiol Infect Dis. 2006 May;25(5):310-7
Publication Type
Article
Date
May-2006
Author
A. Domínguez
P. Plans
J. Costa
N. Torner
N. Cardenosa
J. Batalla
A. Plasencia
L. Salleras
Author Affiliation
Directorate of Public Health, Department of Health, Generalitat of Catalonia, Travessera de les Corts 131-159, 08028, Barcelona, Spain. angela.dominguez@gencat.net
Source
Eur J Clin Microbiol Infect Dis. 2006 May;25(5):310-7
Date
May-2006
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Aged
Aged, 80 and over
Antibodies - blood
Child
Cross-Sectional Studies
Female
Humans
Male
Measles - blood - epidemiology - virology
Middle Aged
Mumps - blood - epidemiology - virology
Rubella - blood - epidemiology - virology
Seroepidemiologic Studies
Spain - epidemiology
Abstract
Determination of antibody levels against vaccine-preventable diseases is of great value to assess immunization programmes. The objective of this study was to determine the prevalence of measles, rubella, and mumps antibodies in representative samples of the child and adult population of Catalonia and compare the findings to those obtained in 1996. A representative sample of the child and adult (>or=15 years) population of Catalonia was studied. Enzyme-linked immunosorbent assay techniques were used to determine the presence of antibodies. Equivocal results for antibodies against measles and rubella were tested using an immunofluorescence technique. To compare proportions, the chi-square test and the Fisher's exact test were used. Statistical significance was set at 0.05. Adjusted odds ratios were calculated using multiple logistic regression analysis. Samples from 2,619 people were analyzed. The global prevalence of antibodies was 98.3% for measles, 91.1% for mumps, and 98.1% for rubella. The prevalence of rubella antibodies was higher in women than in men (98.8 vs. 97.2%, respectively). Compared with the results obtained in the 1996 seroprevalence study, only the prevalence of rubella antibodies showed a statistically significant increase in men (97.2 vs. 94.6%; p=0.002) and, in particular, in women (98.8 vs. 95.3%; p
PubMed ID
16786377 View in PubMed
Less detail

Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain).

https://arctichealth.org/en/permalink/ahliterature164996
Source
Vaccine. 2007 Apr 20;25(16):3240-3
Publication Type
Article
Date
Apr-20-2007
Author
E. Borràs
A. Domínguez
J. Batalla
N. Torner
N. Cardeñosa
M. Nebot
A. Plasencia
L. Salleras
Author Affiliation
Department of Health, Generalitat of Catalonia, Trav. de les Corts 131-159, 08028 Barcelona, Spain. eva.borras@gencat.net
Source
Vaccine. 2007 Apr 20;25(16):3240-3
Date
Apr-20-2007
Language
English
Publication Type
Article
Keywords
Child, Preschool
Cross-Sectional Studies
Emigration and Immigration
Health Services Accessibility - statistics & numerical data
Humans
Immunization Programs - statistics & numerical data - utilization
Infant
Retrospective Studies
Spain
Vaccination - statistics & numerical data - utilization
Abstract
Vaccination coverage in a representative sample of children under 3 years of age in Catalonia (Spain) was studied. Parents of children selected were contacted and asked for the child's vaccination card. A total of 630 children were included, of whom 570 were indigenous and 60 immigrants. Primary vaccination coverage was 96.5% for indigenous and 85% for immigrant children (p=0.0001), while the coverage of primary vaccination plus booster doses was 88.6% in indigenous and 78.3% in immigrant children (p=0.02). Efforts should be made to increase primary vaccination coverage in immigrant children and booster dose coverage in both indigenous and immigrant children.
PubMed ID
17320249 View in PubMed
Less detail